🇺🇸 FDA
Patent

US 7829304

Compounds and related methods for mutant p53 reactivation

granted A61KA61K31/138A61K31/16

Quick answer

US patent 7829304 (Compounds and related methods for mutant p53 reactivation) held by Northwestern University expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/138, A61K31/16, A61K31/24